Motivated by a $5000 bonus, radiologistsat Massachusetts GeneralHospital completed scan signoffs in afraction of the usual time.
Motivated by a $5000 bonus, radiologists at Massachusetts General Hospital completed scan signoffs in a fraction of the usual time.
"We wanted this to be a positive rather than a punitive motivator to try and get radiologists to sign their reports on time," said Dr. Giles Boland, an associate professor of radiology at Massachusetts General Hospital in Boston. "It is unacceptable, for whatever reason, for people to sit on these reports."
A study showed that turnaround times decreased from an average of 19 hours to four within a year of the incentive's introduction.
In an effort to reduce report turnaround times, MGH offered 98 of its radiologists a bonus if they cut the time it took from examination completion to final signature. Some 1.5 million reports were analyzed at the large teaching hospital from 2006 to 2008, which was part of a hospitalwide pay-for-performance program.
The pay-for-performance measure was most profound for the preliminary to final report signoff segment, where turnaround time was reduced by more than 24 hours.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.